Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

2 May 2013 07:00

RNS Number : 8051D
Sopheon PLC
02 May 2013
 



Thursday 2 May 2013

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

INTERIM MANAGEMENT STATEMENT AND CAPITAL REORGANISATION

 

Sopheon plc, the internationalprovider of software and services that improve the financial return from innovation and product development investments, announces its first interim management statement for the period from1 January 2013 to the date of this announcement.

 

Building on 2012's strong performance, revenue visibility for the 2013 full year from contracted business and recurring revenue streams stands at £7.4 million, compared to £6.5 million a year ago. In addition to the maintenance base and some early license wins, much of the visibility relates to ongoing service projects; the first quarter saw a lot of activity with new license opportunities from a mix of new and existing customers, which we are now starting to close during the second quarter.

 

We have continued our recruitment efforts and since the start of the year have added staff in a number of areas, most notably in our European marketing team. This continues our steady expansion of commercial resources in the territory over the last year. Nevertheless we continue to watch revenue performance very closely, given that global markets continue to lack consistency and prediction of the timing and value of individual sales remains challenging.

 

A major product milestone was achieved with the release of Accolade® 8.2, the latest version of our flagship software solution. With this release, businesses are able, for the first time, to access "a single source of the truth" from a fully-integrated solution across the entire innovation management and new product development lifecycle. New features have been added in a range of areas including Portfolio Management, Innovation Planning and Resource Planning. In addition, support has been extended for project teams, extended search and classification, mass import functionality, international languages, and more efficient IT installation, operations, integration and maintenance capabilities. Further details of this milestone release are described in our announcements of 23 January 2013.

 

Capital Reorganisation

 

Notice of Sopheon's forthcoming Annual General Meeting, to be held at the offices of Squire Sanders (UK) LLP, 7 Devonshire Square, London EC2M 4YH at 11:00am on 12 June 2013 is now available on the Sopheon website, along with a circular that describes proposals for a capital reorganisation, to be put to shareholders in a general meeting of the Company to be held immediately after the Annual General Meeting. 

 

As we have previously stated, the goals of the restructuring include consolidating the number of shares, and reducing the accumulated deficit on the profit and loss account. To that end, the Company is proposing a 10000:1 share consolidation that creates Interim Ordinary Shares of £500 each, followed by a subdivision of 1:500 that creates subdivided ordinary shares of £1 each, and finally a re-designation to reduce the nominal value of the resultant ordinary shares to 20p per New Ordinary Share. The Company is also seeking approval to undertake a capital reduction in order to reduce the deficit on its profit and loss account.

 

The proposed timetable for the reorganisation is given below. Due to differences in the settlement mechanisms between the Netherlands and the UK, the record date set out in the proposed timetable for shares in the Netherlands is three days later than in the UK. This is the reason for the one week gap between the Share Consolidation and the Share Subdivision. Notwithstanding the foregoing, trading in the Interim Ordinary Shares will commence on both AIM and Alternext on 17 June 2013, and trading in the New Ordinary Shares will commence on both AIM and Alternext on 24 June 2013.

 

Full details of the proposed reorganisation, including definitions of capitalised terms not defined in this announcement, can be found in the circular.

 

 

Latest time and date for receipt of Proxy Forms

11.30 a.m. on 10 June 2013

General Meeting

11.30am on 12 June 2013

UK Record Date for the Share Consolidation

5.00 p.m. on 14 June 2013

Existing Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 14 June 2013

Admission effective and dealings commence on AIM and Alternext in Interim Ordinary Shares of £500 each

8.00 a.m. on 17 June 2013

CREST accounts credited with Interim Ordinary Shares

17 June 2013

Netherlands Record Date for Share Consolidation

19 June 2013

UK Record Date for Share Subdivision

5.00 p.m. on 21 June 2013

Interim Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 21 June 2013

Admission effective and dealings in New Ordinary Shares commence on AIM and Alternext in New Ordinary Shares of 20p each

8.00 a.m. 24 June 2013

CREST accounts credited with New Ordinary Shares

24 June 2013

Netherlands Record Date for Share Subdivision

26 June 2013

New Share certificates dispatched on or before

1 July 2013

Anticipated date for Reduction of Capital - not later than

31 December 2013

 

 

Accolade® is a registered trademark of Sopheon plc.

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKSFEDXDEFF
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.